Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

3.87USD
23 Feb 2018
Change (% chg)

$0.16 (+4.31%)
Prev Close
$3.71
Open
$3.75
Day's High
$3.94
Day's Low
$3.66
Volume
365,437
Avg. Vol
392,164
52-wk High
$7.88
52-wk Low
$3.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 1.27 1.60 0.75 1.46
Quarter Ending Jun-18 3 1.27 1.60 0.75 1.46
Year Ending Dec-18 4 5.45 6.40 3.00 8.49
Earnings (per share)
Quarter Ending Mar-18 3 -0.13 -0.12 -0.14 -0.23
Quarter Ending Jun-18 3 -0.14 -0.13 -0.15 -0.24
Year Ending Dec-18 4 -0.59 -0.54 -0.64 -0.66
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 192.73 34.59
P/E High - Last 5 Yrs. -- 285.47 45.93
P/E Low - Last 5 Yrs. -- 93.40 24.19
Beta 1.38 0.81 0.81
Price to Sales (TTM) 85.99 137.31 8.08
Price to Book (MRQ) -- 20.28 5.24
Price to Tangible Book (MRQ) 9.27 27.91 6.43
Price to Cash Flow (TTM) -- 126.48 25.98
% Owned Institutions 42.88 11.77 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.87 5.21
Payout Ratio(TTM) -- 8.18 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.00 65.12 9.76
Sales (TTM) vs TTM 1 Yr. Ago -11.05 62.55 7.61
Sales - 5 Yr. Growth Rate 59.39 33.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -13.09 -97.40 18.78
EPS (TTM) vs TTM 1 Yr. Ago 59.50 -- --
EPS - 5 Yr. Growth Rate -- 46.98 11.55
Capital Spending - 5 Yr. Growth Rate -13.77 43.68 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 6.32 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.26 12.18
Total Debt to Equity (MRQ) 0.00 18.35 15.60
Interest Coverage (TTM) -- -160.93 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.39 54.74
Gross Margin - 5 Yr. Avg. -- 55.21 52.50
EBITD Margin (TTM) -795.84 -- --
EBITD - 5 Yr. Avg -3,432.75 -233.45 14.67
Operating Margin (TTM) -800.88 -490.18 4.40
Operating Margin - 5 Yr. Avg. -3,450.43 -250.27 9.99
Pre-Tax Margin (TTM) -818.19 -465.60 5.14
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -256.86 10.24
Net Profit Margin (TTM) -818.19 -447.98 1.86
Net Profit Margin - 5 Yr. Avg. -3,320.66 -260.25 6.55
Effective Tax Rate (TTM) -- 0.27 21.87
Effective Tax Rate - 5 Yr. Avg. -- 17.76 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 23,887,942 823,803,020
Net Income/Employee (TTM) -1,452,056 -537,326 96,327,335
Receivable Turnover (TTM) 336.26 14.02 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.05 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.74 -1.02 10.76
Return on Assets - 5 Yr. Avg. -101.96 -0.09 12.05
Return on Investment (TTM) -52.34 -0.67 13.67
Return on Investment - 5 Yr. Avg. -120.26 2.39 15.78
Return on Equity (TTM) -- -3.38 15.40
Return on Equity - 5 Yr. Avg. -220.88 -1.61 17.04
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.88%
# of Holders: 177
Total Shares Held: 60,879,908
3 Mo. Net Change: -678,922
# New Positions: 22
# Closed Positions: 14
# Increased Positions: 68
# Reduced Positions: 53
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.